972 filings
Page 18 of 49
PRER14A
ACER
Acer Therapeutics Inc.
Preliminary revised proxy
30 Mar 18
12:00am
CORRESP
ACER
Acer Therapeutics Inc.
30 Mar 18
Correspondence with SEC
12:00am
UPLOAD
ACER
Acer Therapeutics Inc.
30 Mar 18
Letter from SEC
12:00am
PRER14A
ACER
Acer Therapeutics Inc.
Preliminary revised proxy
28 Mar 18
12:00am
CORRESP
ACER
Acer Therapeutics Inc.
28 Mar 18
Correspondence with SEC
12:00am
UPLOAD
ACER
Acer Therapeutics Inc.
26 Mar 18
Letter from SEC
12:00am
PRE 14A
ACER
Acer Therapeutics Inc.
Preliminary proxy
12 Mar 18
12:00am
8-K
ACER
Acer Therapeutics Inc.
7 Mar 18
Acer Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
12:00am
10-K
2017 FY
ACER
Acer Therapeutics Inc.
Annual report
7 Mar 18
12:00am
8-K
ACER
Acer Therapeutics Inc.
27 Feb 18
Departure of Directors or Certain Officers
12:00am
SC 13D
ACER
Acer Therapeutics Inc.
16 Feb 18
Acer Therapeutics Inc.
12:00am
4
ACER
Acer Therapeutics Inc.
12 Jan 18
Acer Therapeutics / Hubert Birner ownership change
12:00am
8-K
ACER
Acer Therapeutics Inc.
27 Dec 17
Acer Therapeutics Announces Partial Exercise of Over-allotment Option in Public Offering
12:00am
4
ACER
Acer Therapeutics Inc.
18 Dec 17
Acer Therapeutics / STEVE ASELAGE ownership change
12:00am
8-K
ACER
Acer Therapeutics Inc.
14 Dec 17
Acer Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
12:00am
424B3
ACER
Acer Therapeutics Inc.
12 Dec 17
Prospectus supplement
12:00am
8-K
ACER
Acer Therapeutics Inc.
12 Dec 17
Acer Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
12:00am
424B3
ACER
Acer Therapeutics Inc.
11 Dec 17
Prospectus supplement
12:00am
8-K
ACER
Acer Therapeutics Inc.
11 Dec 17
Acer Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
12:00am
EFFECT
ACER
Acer Therapeutics Inc.
21 Nov 17
Notice of effectiveness
12:00am